Ifosfamide dose-intensification for patients with metastatic Ewing sarcoma

Item

http://www.wikidata.org/entity/Q35760189

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Ifosfamide dose-intensification for patients with metastatic Ewing sarcoma

@ast

Ifosfamide dose-intensification for patients with metastatic Ewing sarcoma

@en

type

Item

label

Ifosfamide dose-intensification for patients with metastatic Ewing sarcoma

@ast

Ifosfamide dose-intensification for patients with metastatic Ewing sarcoma

@en

prefLabel

Ifosfamide dose-intensification for patients with metastatic Ewing sarcoma

@ast

Ifosfamide dose-intensification for patients with metastatic Ewing sarcoma

@en

P1476

Ifosfamide dose-intensification for patients with metastatic Ewing sarcoma

@en

P2093

Christine A Pratilas

http://www.w3.org/2001/XMLSchema#string

Christine M Goodbody

http://www.w3.org/2001/XMLSchema#string

Elyn Riedel

http://www.w3.org/2001/XMLSchema#string

Heather Magnan

http://www.w3.org/2001/XMLSchema#string

Leonard H Wexler

http://www.w3.org/2001/XMLSchema#string

P2860

Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data.

Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.

Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies.

Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998.

Evolving concepts in the systemic drug therapy of breast cancer.

Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group.

Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults.

Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group.

Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies.

P304

594-597

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.25373

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alexander Chou

P577

2015-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25630954

http://www.w3.org/2001/XMLSchema#string

P932

4474186

http://www.w3.org/2001/XMLSchema#string